Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.51 |
| ▸ | IL23R | Q5VWK5 | 5/20 | 0.47 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | TACR3 | P29371 | 1/20 | 0.42 |
| ▸ | CCKBR | P32239 | 2/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | NPY4R | P50391 | 2/20 | 0.39 |
| ▸ | NPY1R | P25929 | 1/20 | 0.39 |
| ▸ | NPY2R | P49146 | 1/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.39 |
| ▸ | EIF4E | P06730 | 1/20 | 0.38 |
| ▸ | EIF4EBP1 | Q13541 | 1/20 | 0.38 |
| ▸ | TFPI | P10646 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30168009 | 1.00 | SIRT5 (0.51) | SIRT5IL23RGNPATTACR3CCKBR | |
| SCHEMBL30463259 | 0.99 | SIRT5 (0.50) | SIRT5IL23RGNPATTACR3CCKBR | |
| SCHEMBL30168003 | 0.99 | SIRT5 (0.50) | SIRT5IL23RGNPATTACR3CCKBR | |
| SCHEMBL31157730 | 0.99 | SIRT5 (0.50) | SIRT5IL23RGNPATTACR3CCKBR | |
| SCHEMBL31157728 | 0.99 | SIRT5 (0.50) | SIRT5IL23RGNPATTACR3CCKBR | |
| SCHEMBL30168002 | 0.99 | SIRT5 (0.50) | SIRT5IL23RGNPATTACR3CCKBR | |
| SCHEMBL31157632 | 0.97 | SIRT5 (0.48) | SIRT5IL23RGNPATTACR3CCKBR | |
| SCHEMBL30463262 | 0.97 | SIRT5 (0.48) | SIRT5IL23RGNPATTACR3CCKBR | |
| SCHEMBL30998021 | 0.96 | SIRT5 (0.53) | SIRT5IL23RGNPATTACR3RXFP1 | |
| SCHEMBL12066140 | 0.96 | SIRT5 (0.53) | SIRT5IL23RGNPATTACR3RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190616-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190616-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | GLA, ALG3, ANXA6 | SIRT5 3611/4885IL23R 4335/4885GNPAT 3557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.